You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Chaperonin/Osmolyte Protein Folding Screen- STTR Phase I

    SBC: EDGE BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): One of the largest bottlenecks in high-throughput protein structure determination (structural genomics) and in subsequent drug targeting (pharmocogenomics) is the acquisition of soluble correctly folded functional protein products. Unfortunately, a large amount of the protein expression systems that are commonly used yield insoluble or soluble misfolded protein ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  2. A daily client check-in system for outpatient substance abuse treatment

    SBC: COG ANALYTICS, LLC            Topic: NIDA

    Abstract Alcohol and illicit drug use remain highly prevalent in the US, and epidemiological surveillance surveys estimate that over 20.6 million individuals (~ 8% of the US population) meet standard diagnostic thresholds for substance use disorders (SAMHSA, 2011). Outpatient substance abuse treatment is the predominate method of treatment in the US for SUDs, typically involving intermittent cont ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Bio-Effects of Ultra-High MRI Gradient Slew Rates

    SBC: WEINBERG MEDICAL PHYSICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The spatial resolution and acquisition times for magnetic resonance imaging and spectroscopy could be improved through the application of more powerful and rapid magnetic gradients, thereby potentially leading to improv ed cardiac imaging and delineation and detection of cancers. Unfortunately, gradient field strength is limited by concerns about potential neur ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Clinical Translation of Augmented Reality Visualization for Laparoscopic Surgery

    SBC: IGI TECHNOLOGIES, INC            Topic: NCI

    DESCRIPTION (provided by applicant): The overall objective of the proposed research is to fully develop and conduct clinical translation of a novel technology that provides minimally invasive surgeons an ability to visualize exposed organ surfaces as wellas structures hidden by them, together with a true appreciation of depth. A long-standing need in minimally invasive laparoscopic surgery has bee ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Computer Asistance for Targeting of Small Pulmonary Nodules in CT-Guided Biopsy

    SBC: KITWARE INC            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of this project is to develop a computer-aided system that can assist the radiologist in targeting small pulmonary nodules during CT-guided lung biopsy. The estimated 3D needle trajectory along with the range of potential needle trajectories given varying degrees of needle steering will be calculated and displayed to the radiologist. We believe ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  6. Confocal Reflectance Microscope with Dual-Wedge Scanner

    SBC: LUCID, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of this project is to design, fabricate, and test a compact, low-cost, confocal reflectance microscope capable of producing images of skin with quality comparable to those of current commercial instruments. The new design uses a scanner concept in which the optical path is passed through two prisms, which are rotated about the beam axis, result ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  7. Dense Medium Plasma Remediation of VOCs in Groundwater

    SBC: Orbital Technologies Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Groundwater is one of the most important freshwater resources on this planet. However, contaminated groundwater has become an ever-increasing problem in the United State. Among the many types of contaminants, Volatile Organic Chemicals (VOCs) are a major concern and a potential human health threat for those who use groundwater for the supply of drinking water. ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  8. Developing a Nrf2 activator for the treatment of COPD

    SBC: CUREVEDA, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity worldwide. In the US alone, the disease afflicts ~13 million people and is the third-leading cause of death. Cigarette smoking isthe primary risk factor for COPD, initiating a persistent and progressive inflammatory immune response. Respiratory infections and pollutants can ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Developing a Nrf2 activator for the treatment of scleroderma

    SBC: CUREVEDA, LLC            Topic: NIAMS

    DESCRIPTION (provided by applicant): Scleroderma is a devastating autoimmune disease with a chronic course, involving the overproduction of collagen leading to fibrosis of the skin and connective tissues. The disease has a range of symptoms including pain,stiffness and swelling of the joints, shortness of breath and gastrointestinal complications. More than 50% of patients with the aggressive form ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Development and in vitro validation of therapy for mucopolysaccharidosis III

    SBC: Phoenix Nest Inc.            Topic: 105

    DESCRIPTION provided by applicant Sanfilippo disease mucopolysaccharidosis type III MPS III is a devastating neurodegenerative lysosomal storage disorder of childhood for which there is no cure or effective treatment available The fundamental cause of MPS III is an inherited mutation in one of the enzymes required to catabolize heparan sulfate HS a glycosaminoglycan which plays importa ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government